OptoAcoustic Ultrasound Imaging Solutions Re-Cap

Asking Price$5,000,000

Cash Flow
$1

EBITDA$1

Gross Revenue$1,500,000

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

listing imageSave

OptoAcoustic Ultrasound Imaging Solutions Re-Cap


Asking Price$5,000,000

Cash Flow
$1

EBITDA$1

Gross Revenue$1,500,000

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

Business Description
We are pleased to be consulting with a premier medical imaging start up company. It was founded in Year 2010 by its owner. While essentially still in a start up mode, this company has been engaged in research and development in this space for the past 15 years. The owner is a pioneer in biomedical optoacoustic imaging. The company specializes in developing proprietary medical imaging devices that combine light and sound to visualize deep tissue structures, vasculature, and microvasculature, aiming to enhance diagnostics, therapy, and surgery for cancer and vascular diseases. Its CEO estimates that they have invested $15M in developing this cutting edge medical imaging technology. The CEO estimates that the company has amassed approximately $25M in patents and IP.

As it approaches its launch, it has developed two initial products beyond functional prototype stage with significant preclinical market fit (24 systems sold with $5M revenue) and a robust pipeline of additional products. The company is seeking a $5M investment to advance its clinical imaging solution through FDA approval and commercial launch, which is projected for Year 2026.

Its technology and product offering is poised to disrupt the large and growing vascular imaging markets and screening with simultaneous diagnostics of early but aggressive breast cancer and other aggressive cancers using innovative, safe, non-invasive, accurate, and inexpensive imaging solutions with the potential to significantly improve the standard of care. Pending a successful ADA approval in Year 2026, the company boasts a revenue forecast to over $60M by Year 2029, which would turn a $5M investment in the company to $15M, for a 300% return in approximately four years..

The Market of medical imaging procedures reached $42.7 Billion globally in 2024 and expected to grow to 70.19 billion in 2032, exhibiting a CAGR of 6.4% during the next decade. The CEO seeks to sell a 25% stake in the company for $5M.

Please note that due to the very sensitive nature of this proposed transaction, a detailed NDA will be required to be completed before confidential company details are provided. Please also note that the company's actual zip code was changed to help protect its confidentiality. However, this company is in fact, located in the state of Texas.
About the Business
Years in Operation
15
Employees
20
Listing Info
ID
2366614
Listing Views
737

Contact Seller

By clicking the button, you agree to BizQuest's Terms of Use and Privacy Notice.

Business Listed by: Douglas Batts Murphy Business & Financial Services

Listing ID: 2366614 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.


Similar Listings